|
Market Closed -
Nasdaq
00:00:00 19/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 34.88 USD | -2.27% |
|
+1.13% | -2.79% |
| 08-04 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-04 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
| Market Cap | 4.12B 3.59B 3.39B 3.08B 5.77B 395B 5.79B 40.6B 15.67B 201B 15.46B 15.12B 646B | P/E 2026 * |
9.38x | P/E 2027 * | 8.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.1B 3.58B 3.38B 3.07B 5.75B 394B 5.77B 40.47B 15.62B 200B 15.42B 15.07B 644B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 2.53x |
| Free-Float |
98.18% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INDV | Delayed | |
CBOE
| INDV | Real-time | |
|
Deutsche Boerse AG
| E7P | Delayed | |
|
Tradegate
| E7P | Real-time | |
|
Boerse Muenchen
| E7P | Real-time | |
|
Xetra
| E7P | Delayed |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -2.27% | ||
| 1 week | +1.13% | ||
| Current month | -0.14% | ||
| 1 month | -10.66% | ||
| 3 months | -8.93% | ||
| 6 months | +14.36% | ||
| Current year | -2.79% |
| 1 week | 33.74 |  | 35.9 |
| 1 month | 33.74 | | 38.52 |
| Current year | 27.68 | | 42.81 |
| 1 year | 22.3 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 05/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | +1.13% | +54.95% | +60.76% | 4.12B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | -0.19% | +3.04% | +28.22% | +46.89% | 360.58B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.87% | +61.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.16B 1.1B 996M 1.87B 128B 1.87B 13.14B 5.07B 64.98B 5B 4.89B 209B | 1.4B 1.22B 1.15B 1.05B 1.96B 134B 1.97B 13.8B 5.33B 68.28B 5.26B 5.14B 220B |
| Net income | 474M 414M 390M 355M 664M 45.51B 667M 4.68B 1.81B 23.14B 1.78B 1.74B 74.45B | 530M 462M 436M 396M 742M 50.85B 746M 5.23B 2.02B 25.85B 1.99B 1.95B 83.19B |
| Net Debt | -12.5M -10.9M -10.29M -9.35M -17.51M -1.2B -17.58M -123M -47.58M -610M -46.96M -45.91M -1.96B | -570M -497M -469M -426M -798M -54.69B -802M -5.62B -2.17B -27.81B -2.14B -2.09B -89.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $34.88 | -2.27% | 4,684,180 |
| 17/09/26 | $35.69 | +3.90% | 2,690,502 |
| 16/09/26 | $34.35 | +0.38% | 1,865,882 |
| 15/09/26 | $34.22 | -0.73% | 2,700,651 |
| 14/09/26 | $34.47 | -0.06% | 3,429,258 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
